Sensifai
11 employees on LinkedIn · 2 known investors
Find your way into Sensifai
Each arrow is one introduction. Sign up to fill in the first one.
106 people can intro you to Dennis
Ask Samuel Ohayon to introduce you to Dennis Jensen
You →Samuel · together at Sensifai →Dennis
Sign up to find every way you can get introduced to Sensifai
- Your email: who you already know at Sensifai, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sensifai team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Sensifai develops predictive health solutions that use scientific expertise to identify and prevent illness before it occurs. The company serves clinicians, researchers, and patients through technology combining clinical and engineering talent.
Founders & leadership
DJ

Dennis JensenCo-founder, CSODennis Jensen holds an Associate Professor position and Canada Research Chair in Clinical Exercise and Respiratory Physiology, with research expertise in pulmonary disease management, exercise physiology, and wearable biosensor applications for illness detection. He applies clinical and experimental methods including diaphragm electromyography and machine learning to advance understanding of respiratory disease in adults.
Board
JB
Jean BourbeauClinical Advisor
Investors · 2
Glen VenturesreportedMontreal
How we know: funding news · press coverage · Not right? Tell us
In the news
Frequently asked questions
- What does Sensifai do?
- Sensifai develops predictive health solutions that use scientific expertise to identify and prevent illness before it occurs. The company serves clinicians, researchers, and patients through technology combining clinical and engineering talent.
- Who founded Sensifai?
- Sensifai was founded by Dennis Jensen.
- Who are Sensifai's investors?
- Sensifai's investors include Longevity Venture Partners, Glen Ventures.

